2022
DOI: 10.1016/j.mvr.2022.104378
|View full text |Cite
|
Sign up to set email alerts
|

The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 48 publications
0
3
0
1
Order By: Relevance
“…HK2 [269], PNPLA3 [270], CPB2 [271], SEMA4C [272], LRP2 [273], SLC5A11 [274], F11 [275], ANGPTL2 [276] and CYP2A6 [277] genes might be related to the pathophysiology of autoimmune disease. A recent study revealed that SLAMF7 [278], FCRL3 [279], CCR4 [280], GZMA (granzyme A) [281], CCR2 [282], CD48 [283], CD3E [284], CCL4 [285], FASLG (Fas ligand) [286], SLAMF1 [287], CD28 [288], IL7R [289], UBASH3A [290], CD3D [291], ICOS (inducible T cell costimulator) [292], CCL5 [293], CCL3 [294], LTF (lactotransferrin) [295], CTLA4 [296], TNFRSF9 [253], C6 [297], IL5RA [298], IL2RG [299], NPY2R [300], DRD3 [301], CD52 [302], CD163 [303], IQGAP2 [304], PRPH (peripherin) [305], MSR1 [306], HGF (hepatocyte growth factor) [307], TTR (transthyretin) [308], IL9 [309], ADM (adrenomedullin) [310], ANGPTL4 [311], CHI3L1 [312], CDH1 [313], SREBF1 [314], CDKN1C [315], TSC22D4 [316], CFTR (CF transmembrane conductance regulator) [317], INSIG1 [318], HSD17B3 [319], GREM1 [320], ATF3 [321], HK2 [322], TF (transferrin) [323], GLUL (glutamate-ammonia ligase) [324], DMRT2 [325], FN3K [326], TREH (trehalase) [327], ADAMTS4 [328], BMP2 [329], LMNA (lamin A/C) [330], ERBB3 [331], HSD11B1 [332], DLL1 [333], NKX2-2 [334], FGF11 [335], ASPA (aspartoacylase) [336], FASN (fatty acid synthase) [337], PNPLA3 [338], ADORA1 [339], WNT7A [340…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…HK2 [269], PNPLA3 [270], CPB2 [271], SEMA4C [272], LRP2 [273], SLC5A11 [274], F11 [275], ANGPTL2 [276] and CYP2A6 [277] genes might be related to the pathophysiology of autoimmune disease. A recent study revealed that SLAMF7 [278], FCRL3 [279], CCR4 [280], GZMA (granzyme A) [281], CCR2 [282], CD48 [283], CD3E [284], CCL4 [285], FASLG (Fas ligand) [286], SLAMF1 [287], CD28 [288], IL7R [289], UBASH3A [290], CD3D [291], ICOS (inducible T cell costimulator) [292], CCL5 [293], CCL3 [294], LTF (lactotransferrin) [295], CTLA4 [296], TNFRSF9 [253], C6 [297], IL5RA [298], IL2RG [299], NPY2R [300], DRD3 [301], CD52 [302], CD163 [303], IQGAP2 [304], PRPH (peripherin) [305], MSR1 [306], HGF (hepatocyte growth factor) [307], TTR (transthyretin) [308], IL9 [309], ADM (adrenomedullin) [310], ANGPTL4 [311], CHI3L1 [312], CDH1 [313], SREBF1 [314], CDKN1C [315], TSC22D4 [316], CFTR (CF transmembrane conductance regulator) [317], INSIG1 [318], HSD17B3 [319], GREM1 [320], ATF3 [321], HK2 [322], TF (transferrin) [323], GLUL (glutamate-ammonia ligase) [324], DMRT2 [325], FN3K [326], TREH (trehalase) [327], ADAMTS4 [328], BMP2 [329], LMNA (lamin A/C) [330], ERBB3 [331], HSD11B1 [332], DLL1 [333], NKX2-2 [334], FGF11 [335], ASPA (aspartoacylase) [336], FASN (fatty acid synthase) [337], PNPLA3 [338], ADORA1 [339], WNT7A [340…”
Section: Discussionmentioning
confidence: 99%
“…SLAMF1 [237], TAB2 [256] and HGF (hepatocyte growth factor) [260] might play an important role in the onset, development, and treatment of autoimmune disease. SLAMF1 [287], CFTR (CF transmembrane conductance regulator) [317], LMNA (lamin A/C) [330], ERBB3 [331], HGF (hepatocyte growth factor) [307] and CCL5 [293] might play an important role in the pathophysiology of diabetes mellitus. TAB2 [131], LMNA (lamin A/C) [168], ERBB3 [169], HGF (hepatocyte growth factor) [135] and CCL5 [124] were abnormally expressed in cardiovascular diseases.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…También, en diabetes tipo 1, se analizaron polimorfismos del gen ERBB3 (rs705708 alelo A) y su regulador PA2G4 (rs773120), que son polimorfismos que se han estudiado por su aparente relación con el riesgo para padecer diabetes tipo 1. En este estudio no se encontró relación del rs705708 alelo A con el riesgo de padecer diabetes tipo I, pero sí con padecerla a una edad más temprana, sin embargo se encontró asociado a un menor riesgo de padecer RD e hipertensión 22 .…”
Section: Mexicana Sin Especificar Etniaunclassified